Skip Nav Destination
Issues
Journal Name Change
Vol. 1-20 (1948-1966) were published under the journal's former title Oncologia.
Oncology 2023, Vol. 101, No. 4
Clinical Study
The Impact of Poorly Differentiated Histology on Immunotherapy in Advanced Gastrointestinal Cancers
Topic Article Package:
Topic Article Package: ADC (Antibody-Drug Conjugates)
Special Collection:
Karger e-Journal Backfile Collection 2023
Subject Area:
Oncology
Amber Draper; Emily H. Jung; Yichun Cao; Rami P. Atallah; Jeffrey Switchenko; Sujata Kane; Jessica Guadagno; Aaron T. Jones; Edith Brutcher; Olatunji B. Alese
Oncology (2023) 101 (4): 213–223.
https://doi.org/10.1159/000527992
GNRI Sustainability during One Cycle of First-Line Chemotherapy as a Prognostic Indicator in Patients with Metastatic Urothelial Carcinoma
Topic Article Package:
Topic Article Package: ADC (Antibody-Drug Conjugates)
Special Collection:
Karger e-Journal Backfile Collection 2023
Subject Area:
Oncology
Yosuke Sugiyama; Taku Naiki; Yoshihiko Tasaki; Yoshihisa Mimura; Toshiki Etani; Yusuke Noda; Satoshi Nozaki; Nobuhiko Shimizu; Rika Banno; Takashi Nagai; Teruki Isobe; Ryosuke Ando; Yoshinobu Moritoki; Tomoya Kataoka; Kunihiro Odagiri; Maria Aoki; Masakazu Gonda; Takahiro Yasui; Yoko Hibi
Oncology (2023) 101 (4): 224–233.
https://doi.org/10.1159/000529203
The Complex Management of the Breast Angiosarcoma: A Retrospective Study
Special Collection:
Karger e-Journal Backfile Collection 2023
Subject Area:
Oncology
Lucia Cannella; Francesco Perri; Ottavia Clemente; Claudia von Arx; Antonio Pizzolorusso; Maurizio Di Bonito; Alessandra Bracigliano; Massimiliano Di Marzo; Giuseppina Della Vittoria Scarpati; Annarosaria De Chiara; Salvatore Tafuto
Oncology (2023) 101 (4): 234–239.
https://doi.org/10.1159/000525146
Clinical Translational Research
Clinico-Radio-Histo-Molecular and Neurocognitive Characteristics of Diffuse Gliomas in Adolescent and Young Adults: A Comprehensive Review
Special Collection:
Karger e-Journal Backfile Collection 2023
Subject Area:
Oncology
Alexandre Roux; Marc Zanello; Giorgia Antonia Simboli; Pascale Varlet; Arnault Tauziede-Espariat; Kévin Beccaria; Thomas Blauwblomme; Stéphanie Puget; Catherine Oppenheim; Volodia Dangouloff-Ros; Nathalie Boddaert; Frédéric Dhermain; Christelle Dufour; Jacques Grill; Fabrice Chretien; Johan Pallud
Oncology (2023) 101 (4): 240–251.
https://doi.org/10.1159/000528588
Why Oncologists Should Feel Directly Involved in Persuading Patients with Head and Neck Cancer to Quit Smoking
Special Collection:
Karger e-Journal Backfile Collection 2023
Subject Area:
Oncology
Marco Carlo Merlano; Nerina Denaro; Danilo Galizia; Andrea Abbona; Matteo Paccagnella; Silvia Minei; Ornella Garrone; Paolo Bossi
Oncology (2023) 101 (4): 252–256.
https://doi.org/10.1159/000528345
Clinical Trial Note
Clinical Efficacy and Safety of Ni<underline>v</underline>olumab in Mal<underline>i</underline>gnant N<underline>o</underline>n-Pleural Mesothe<underline>l</underline>iom<underline>a</underline>: A Multicenter, Open-Label, Single-Arm, Japanese Phase II Trial (VIOLA) Protocol
Special Collection:
Karger e-Journal Backfile Collection 2023
Subject Area:
Oncology
Kozo Kuribayashi; Masataka Igeta; Takashi Daimon; Maede Ibu; Shinichiro Suna; Rika Okamoto; Takashi Kijima
Oncology (2023) 101 (4): 257–261.
https://doi.org/10.1159/000528791
Research Article
Outcomes and Prognostic Factors in HER2-Positive Metastatic Breast Cancer Patients Who Had Developed Brain Metastasis in the Treatment Process
Topic Article Package:
Topic Article Package: ADC (Antibody-Drug Conjugates)
Special Collection:
Karger e-Journal Backfile Collection 2023
Subject Area:
Oncology
Izzet Dogan; Inci Kizildag; Selnur Özkurt; Kamuran Ibis; Sezai Vatansever; Pinar Saip; Adnan Aydiner
Oncology (2023) 101 (4): 262–269.
https://doi.org/10.1159/000529030
Nutritional Status Is Associated with Prognosis in Patients with Advanced Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab
Special Collection:
Karger e-Journal Backfile Collection 2023
Subject Area:
Oncology
Toshifumi Tada; Takashi Kumada; Atsushi Hiraoka; Kazuya Kariyama; Joji Tani; Masashi Hirooka; Koichi Takaguchi; Masanori Atsukawa; Shinya Fukunishi; Ei Itobayashi; Kunihiko Tsuji; Kazuto Tajiri; Hironori Ochi; Toru Ishikawa; Satoshi Yasuda; Chikara Ogawa; Hidenori Toyoda; Takeshi Hatanaka; Takashi Nishimura; Satoru Kakizaki; Kazuhito Kawata; Noritomo Shimada; Fujimasa Tada; Kazuhiro Nouso; Akemi Tsutsui; Hideko Ohama; Asahiro Morishita; Takuya Nagano; Norio Itokawa; Tomomi Okubo; Taeang Arai; Hisashi Kosaka; Michitaka Imai; Atsushi Naganuma; Shinichiro Nakamura; Yohei Koizumi; Tomomitsu Matono; Masaki Kaibori; Hiroko Iijima; Yoichi Hiasa; on behalf of the Real-life Practice Experts for HCC (RELPEC) Study Group and the Hepatocellular Carcinoma Experts from 48 clinics in Japan (HCC 48) Group; Hepatocellular Carcinoma Experts from 48 clinics in Japan (HCC 48) Group
Oncology (2023) 101 (4): 270–282.
https://doi.org/10.1159/000527676
